Wealth and Asset Management
UBS clients raise $650 million for biggest yet biotech impact fund
UBS's wealthy clients have raised $650 million for the biggest biotechnology impact fund ever, the Swiss bank said on Wednesday. Impact investing – a term coined in 2007 – grew out of the desire to extend philanthropic goals into mainstream financial holdings. Alongside financial returns, impact investments aim to generate…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Yahoo News